Form 4: Generation Bio CSO Steps Down, Ends SEC Reporting
Executive Change Notification
Phillip Samayoa will cease to be Generation Bio Co.'s Chief Scientific Officer and will no longer be subject to Section 16 reporting requirements as of October 31, 2025.
Summary
- Phillip Samayoa, Chief Scientific Officer of Generation Bio Co. (GBIO), will no longer hold this position effective October 31, 2025.
- As a result of this change, Samayoa will no longer be subject to Section 16 of the Securities Exchange Act of 1934, which mandates reporting of equity security transactions by officers, directors, and 10% owners.
- This Form 4 filing serves as notification to the SEC regarding the cessation of his reporting obligations.
Sentiment
Score: 5
Explanation: Neutral. The filing is purely administrative, reporting a change in an executive's role and subsequent cessation of Section 16 reporting obligations. It provides no information on company performance or strategic direction.
Future Outlook
NA
Industry Context
NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Scientific Officer | Phillip Samayoa | NA | 10/31/2025 | Cessation of service as Chief Scientific Officer, leading to no longer being subject to Section 16 reporting requirements. |
Stakeholder Impact
- Shareholders: May note the departure of a key executive, potentially raising questions about leadership stability or strategic direction, though this filing itself provides no further context.
Key Dates
| Date | Description |
|---|---|
| 10/31/2025 | Effective date Phillip Samayoa will no longer serve as Chief Scientific Officer of Generation Bio Co. |
| 10/31/2025 | Date of filing signature by Attorney-in-Fact. |
Keywords
Generation Bio Co., GBIO, Phillip Samayoa, Chief Scientific Officer, CSO, SEC Form 4, Section 16, Executive Departure, Biotechnology, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.